VEA
CTIC

Virtus ETF Advisers’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Virtus ETF Advisers’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-52,472
Closed -$220K – 494
2023
Q1 		$220K Buy
52,472
+930
+2% +$3.91K 0.12% 300
2022
Q4 		$310K Buy
51,542
+8,172
+19% +$49.1K 0.16% 250
2022
Q3 		$252K Buy
43,370
+635
+1% +$3.69K 0.1% 288
2022
Q2 		$255K Buy
+42,735
New +$255K 0.09% 293